NCT04539327 2026-03-18
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo EspaƱol de InvestigaciĆ³n en CĆ”ncer de Ovario
Completed
Clinical Trials
406 trialsNCT03239145 2026-03-12
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Phase 1 Completed
NCT03367247 2026-03-10
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Dana-Farber Cancer Institute
Phase NA Completed
NCT03617679 2026-02-23
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
University of Colorado, Denver
Phase 2 Active not recruiting
NCT03734692 2026-02-12
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer
University of Pittsburgh
Phase 1/2 Active not recruiting
NCT03763838 2026-02-05
Acupressure for Fatigue in Ovarian Cancer Survivors
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT03120624 2026-02-04
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
Mayo Clinic
Phase 1 Active not recruiting
NCT02405221 2026-01-29
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03984695 2026-01-28
SHE-WOMEN
University of Kansas Medical Center
Phase NA Active not recruiting
NCT05082025 2026-01-09
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01048853 2026-01-07
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
M.D. Anderson Cancer Center
Phase NA Terminated
NCT03671811 2026-01-06
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
City of Hope Medical Center
Phase 2 Active not recruiting
NCT04670068 2025-12-22
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
UNC Lineberger Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT03422198 2025-12-12
SAVE
University of Utah
Phase 3 Recruiting
NCT04339140 2025-12-11
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT04905082 2025-12-11
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
Phase NA Active not recruiting
NCT01068249 2025-11-18
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT02068794 2025-11-18
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Mayo Clinic
Phase 1/2 Active not recruiting
NCT01676818 2025-11-06
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
University of Southern California
Phase 2 Completed
NCT03188432 2025-10-21
Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT04025229 2025-10-15
High Intensity Interval Training in Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT04363957 2025-10-14
Gynecologic Brachytherapy-Specific Educational Video
University of California, San Diego
Phase NA Completed
NCT05263492 2025-10-02
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Virginia Commonwealth University
Phase 2 Terminated
NCT04259762 2025-09-24
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
New Mexico Cancer Research Alliance
Phase NA Completed
NCT05036681 2025-09-17
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT05708703 2025-09-16
Assessing the Time Demands of Cancer
Masonic Cancer Center, University of Minnesota
Active not recruiting
NCT03426878 2025-09-11
CHARM
Kaiser Permanente
Phase NA Completed
NCT03022032 2025-09-09
The HOPE Trial and the SMART Study
Dana-Farber Cancer Institute
Phase NA Completed
NCT03085225 2025-09-04
TRAMUNE
Institut BergoniƩ
Phase 1 Completed
NCT03898167 2025-09-04
PRESTIS
Baylor College of Medicine
Phase NA Completed
NCT00766142 2025-08-29
COCHISE
Institut BergoniƩ
Phase 2 Terminated
NCT05105087 2025-08-22
Gynecological Sentinel Lymph Nodes CEUS
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT00788671 2025-08-15
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05708924 2025-08-14
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated
NCT04611126 2025-08-12
T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer
Herlev Hospital
Phase 1/2 Terminated
NCT04092257 2025-08-06
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT06048367 2025-08-03
CNSI-Fe(II)
Sichuan Enray Pharmaceutical Sciences Company
Phase 1 Completed
NCT02912572 2025-07-10
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT05453006 2025-07-10
Isbaar
University of Minnesota
Phase NA Completed
NCT02821793 2025-07-01
PRIORITY
Institut BergoniƩ
Completed
NCT04608409 2025-06-29
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
University of Kentucky
Phase 1 Completed
NCT04998318 2025-06-24
1:1 Comparison of the Pocket Colposcope in Kenya
Duke University
Phase NA Completed
NCT04503668 2025-06-18
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
University of Michigan Rogel Cancer Center
Phase 3 Terminated
NCT02899793 2025-06-11
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Yale University
Phase 2 Completed
NCT03783949 2025-06-11
EUDARIO
Universitaire Ziekenhuizen KU Leuven
Phase 2 Completed
NCT04019288 2025-06-11
AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT02520154 2025-06-08
Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02228889 2025-06-06
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Phase NA Completed
NCT03694262 2025-05-30
EndoBARR
Medical College of Wisconsin
Phase 2 Active not recruiting
NCT03326713 2025-05-28
GRACE
Rutgers, The State University of New Jersey
Phase NA Completed